TBTimothy Brown

Timothy Brown

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Timothy Brown has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Differences in secondary-task engagement and vehicle control among occasional and daily cannabis users

    by Timothy Brown, Ashley Brooks-Russell, Julia Wrobel, Jonny Kuo, Mike Lenne

    In the United States and globally, perceptions of cannabis related risk—and the legal status of cannabis for medical and recreational use—have changed markedly. As of early 2026 in the United State...

  • How standard deviation of lane position is affected by driving environment and driver characteristics: implications for baseline driving performance

    by Timothy Brown, Gary Milavetz, Chris Schwarz, Rose Schmitt, Cheryl Roe, Dawn Marshall, Gary Gaffney

    Driving simulators are used for a variety of purposes (Carsten and Jamson 2011), including driver training (Alonso et al. 2023), evaluating safety systems (Boyle and Lee 2010), studying driver beha...

  • Clustering Roadway Departures from Impaired Driving Studies using Derived Features and Shape-Based Methods

    by Ryan Miller, Arsal Shaikh, Tannishtha Mukherjee, Chris Schwarz, Timothy Brown

    Lane departures remain a major contributor to fatal traffic accidents despite the increasing adoption of lane departure warning systems. Existing research has focused on the detection and mitigation of lane departures, while the characteristics of departures and their potential relationships with categories of driver impairment have received less attention. We apply a variety of unsupervised clustering approaches to a comprehensive set of lane departures from three drug-impaired driving studies involving combinations of cannabis and low-dose alcohol, alcohol, and cannabis. We find that departures are more frequent in active-drug conditions, ranging from 26% to 222% increases in mean departures per minute of driving depending on the study and condition. Across all studies, departures are most effectively grouped into two clusters based on duration and peak lateral deviation, with average silhouette scores of the most effective approaches being 0.778, 0.759, and 0.871, respectively, indicating high degrees of cohesion within clusters and separation between them. After clustering on the principal components derived from driving data from before, during, and after each departure we find clusters that differ significantly in their relative proportions of alcohol-dosed drivers ( p < 0.001). Shape-based approaches also identify two clusters of departures that differ in duration, maximum deviation, and timing of peak deviation. These clusters contain a significantly different composition of dosing conditions in the combined alcohol and cannabis study ( p = 0.015). Our results suggest lane departures can be effectively profiled and that leveraging their characteristics may benefit driver monitoring systems targeting the detection of drug-impaired driving.

  • Edible cannabis use on simulated driving performance

    by Nae Y. Won, Sarah Bird, Julia Wrobel, Timothy Brown, Ashley Brooks-Russell

    To assess driving performance after consuming edible cannabis using a driving simulator, examining frequency of use, THC dose, and rural versus urban settings. Adults in Denver, Colorado (N = 88), between 25 and 55 years old, were recruited from November 2023 to July 2024 and assigned to groups based on past 90-day cannabis use: daily (N = 29), occasional (N = 30), or no recent use (i.e., comparison group; N = 29). This within-subjects study compared driving performance (i.e., speed, lane departures per minute, and standard deviation of lateral placement (SDLP)) using a validated driving simulator (miniSim™) at baseline and two post-consumption tests (52 and 119 min). Linear mixed models were used to evaluate performance. Daily-use group drove slower than the occasional-use group (decrease in average speed from pretest of 2.49 mph (urban, p < 0.01 post-1); 1.80 mph (p = 0.02 post-2)) and the comparison group (decrease in average speed from pretest of 2.70 mph (urban, p < 0.01 post-1); 2.68 mph (urban, p < 0.01 post-2)). Lane departures increased in the occasional-use group from 0.17 at pretest to 0.47 in post-1 and 0.40 in post-2 (p < 0.01). Their rural SDLP increased: post-1 (29.37 cm, p < 0.01), post-2 (29.81 cm, p < 0.01), versus pretest (25.45 cm). This group had significantly greater change in lane departures than both the comparison group (0.26, p < 0.01) and daily-use group (0.34, p < 0.01) in post-1. In post-2, the change remained greater than the daily-use group (0.20, p = 0.02). Our study found significant changes in driving performance following edible cannabis use, including findings related to effect duration, use frequency, and road settings. The occasional-use group showed greater impairment than daily-use group, suggesting tolerance contributes to outcomes beyond THC concentration alone.


  • Detecting Impaired Driving: Vehicle Inputs with the Greatest Influence on Accurate Identification

    by Ryan Miller, Bradley Carlton, Timothy Brown

    Alcohol and drug impairment are major causes of crashes and fatalities. Despite evidence of significant differences in lateral control, speed, and steering across impaired and sober states, leveraging this information for the automated detection of impairment using vehicle inputs remains a challenge. Using data from two driving simulator studies involving sources of impairment (cannabis, alcohol, and combined cannabis and alcohol) and a range of driving environments, we develop machine learning models to identify acute drug use using vehicle data with a focus on understanding which features exert the greatest influence on predictions across a variety of scenarios. Under a robust validation framework, we used SHapley Additive exPlanations to determine that features derived from lateral position were consistently among the most predictive, whereas vehicle speed, steering wheel rate, and brake force also made meaningful contributions. Features derived from lateral position were more predictive when calculated over longer periods (60 s) relative to shorter time spans (0.33 to 5 s). Leveraging subject-specific information tended to improve classification performance. For detecting recent cannabis use (~30-min postdose), receiver operating characteristic—area under the curve (AUC) improved from 0.0625 to 0.706 in a straight, two-lane rural road scenario, and for classifying combined cannabis and alcohol impairment ROC-AUC improved from 0.643 to 0.689 on a straight segment of a four-lane divided expressway. These findings highlight the potential for carefully selected features derived from vehicle inputs to contribute to automated impairment detection, and the need to consider driving environments and sources of impairment when using these features.

  • Impact of naturalistic cannabis use on lateral control and speed: A driving simulator study

    by Ashley Brooks-Russell, Sarah Bird, Timothy Brown, Sarah Limbacher, Michael Kosnett, Greg Dooley, Julia Wrobel

    Cannabis has been shown to impair driving performance, but much of extant research has been conducted with relatively low concentration products, not reflective of the marketplace in states with legal adult recreational cannabis use. The study examined driving performance after cannabis use, inclusive of high concentration tetrahydrocannabinol (THC) products. Participants (n = 118) completed three 20-minute simulated drives, with rural and urban segments. The study was within-subjects; participants completed a pre-use (baseline) drive, and two post-use drives at approximately 30 min and an hour and a half after cannabis use. Of participants, n = 89 inhaled cannabis products (flower or concentrates) ad libitum for up to 15 min and n = 29 participants completed the protocol without using cannabis. Outcomes included lane departures, standard deviation of lateral placement [SDLP], average speed, and standard deviation of speed. Primary predictors were time-point, and group based on cannabis use frequency and product used in the study (control group; occasional-flower; daily-flower; daily-concentrate). There were significant changes in lane departures, SDLP and speed measures from baseline to post use, depending on the participant group and time point. When compared to the control group, the occasional-flower group had a greater increase in rate of lane departures (0.16 departures/minute at baseline and 0.47 at Post 1, p < 0.01). In contrast, the daily-concentrate group had an improvement in SDLP (27.2 to 26.1 cm at Post 1) compared to the control group (23.9 to 25.7 cm; p = 0.04). The daily-flower and occasional-flower groups had little to no change in average speed from pre- to post-cannabis use (e.g., 53.9 mph at baseline and Post 1, daily-flower group) whereas the control group increased speed (e.g., 53.9 to 54.6 mph, baseline to Post 1). There were additional significant differences between the groups. Within and between group differences in change were relatively small. The occasional-flower group exhibited an increase in lane departures, not seen in other groups, consistent with tolerance in the daily-use groups. There was a notable absence of declines in driving performance for the daily-concentrate group. Changes in driving performance were relatively small across all groups.


  • Assessing the impact of cannabis use on freeway driving performance and practices: A comparative analysis with placebo and alcohol-influenced driving

    by Timothy Brown, Cole Kruse, Rose Schmitt, Gary Gaffney, Gary Milavetz

    The objectives of this study were 1) to identify the effects cannabis has on driving performance and individual motor practices when on the freeway compared to placebo and 2) to bring context to the effects of cannabis on driving by comparing effect sizes to those of alcohol. Data for analysis was collected from a study of fifty-three participants with a history of tetrahydrocannabinol (THC) cannabis use who completed three visits in randomized order (placebo (0% THC), 6.18% THC, and 10.5% THC). Data for the alcohol analysis was from a subset of eighteen of these participants with a history of recent alcohol use that completed a fourth alcohol visit that targeted a .05 g/210L breath alcohol content (BrAC) during the drive. Comparisons were made using an analysis of variance approach with the SAS General Linear Models Procedure. Cohen's d effect sizes were calculated for the cannabis and alcohol conditions relative to placebo for both the full sample and alcohol subset. Standard deviation of lane position (SDLP) for cannabis significantly increased compared to placebo and the effect size was comparable to that of alcohol at .05 BrAC. Lane departures for cannabis significantly increased relative to placebo as did the time out of the lane. Cannabis use resulted in an increased amount of time at 10% or more below the speed limit for the 6.18% THC condition. Relative to alcohol, cannabis produced more time at slower speeds and less time at speeds more than 10% above the speed limit. Multiple factors of lateral and longitudinal vehicle control on the freeway showed statistical significance. Drivers under the influence of cannabis exhibited higher rates of driving errors but also showed more cautious behaviors such as generally lower speeds on the freeway. Compared with alcohol, effect sizes varied. For longitudinal control, there were larger effect sizes for alcohol with speed effects in opposite directions, but relatively equivalent effect sizes for lateral control and driving errors associated with lane keeping.


  • Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking

    by Michael J. Kosnett, Ming Ma, Gregory Dooley, George Sam Wang, Kyle Friedman, Timothy Brown, Thomas K. Henthorn, Ashley Brooks-Russell

    Cannabis use is a growing concern in transportation and workplace incidents. Because Δ9-tetrahydrocannabinol is detectable after acute psychoactive effects have resolved, it has limitations as an indicator of recent usage or potential impairment. In an observational study of driving and psychomotor performance, we measured whole blood Δ9-tetrahydrocannabinol plus its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol by liquid chromatography with tandem mass spectrometry at baseline and 30 min after starting a 15-minute interval of smoking cannabis in 24 occasional and 32 daily cannabis smokers. We calculated two blood cannabinoid molar metabolite ratios: 1) [Δ9-tetrahydrocannabinol] to [11-nor-9-carboxy-Δ9-tetrahydrocannabinol] and 2) ([Δ9-tetrahydrocannabinol] + [11-hydroxy-Δ9-tetrahydrocannabinol]) to [11-nor-9-carboxy-Δ9-tetrahydrocannabinol]. We compared these to blood [Δ9-tetrahydrocannabinol] alone as indicators of recent cannabis smoking. Median Δ9-tetrahydrocannabinol concentrations increased from 0 ( 0.38). By comparison, a cut-point for Δ9-tetrahydrocannabinol of 5.3 µg/L yielded 88% specificity, 73% sensitivity, and 80% accuracy. In occasional and daily users, the blood cannabinoid molar metabolite ratios were superior to whole blood Δ9-tetrahydrocannabinol as indicators of recent cannabis smoking. We recommend measurement and reporting of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol, and their molar metabolite ratios in forensic and safety investigations.


  • Perceived effects of cannabis: Generalizability of changes in driving performance

    by Thomas S. Burt, Timothy L. Brown, Rose Schmitt, Daniel McGehee, Gary Milavetz, Gary Gaffney, Chris Berka

    The objective of this analysis was to determine the generalizability of the relationship between different samples of a driver’s perceived state after cannabis use and related performance while ope...